SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
18296424
Source:
http://linkedlifedata.com/resource/pubmed/id/18296424
Search
Subject
(
56
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0205210
,
umls-concept:C0278488
,
umls-concept:C0879262
,
umls-concept:C1516213
pubmed:issue
3
pubmed:dateCreated
2008-3-13
pubmed:abstractText
S-1, an oral fluoropyrimidine carbamate, is an active and well-tolerated agent against solid cancer. However, the clinical efficacy of S-1 in patients with metastatic breast cancer has not been determined.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0313225
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic
,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations
,
http://linkedlifedata.com/resource/pubmed/chemical/Oxonic Acid
,
http://linkedlifedata.com/resource/pubmed/chemical/S 1 (combination)
,
http://linkedlifedata.com/resource/pubmed/chemical/Tegafur
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1465-3621
pubmed:author
pubmed-author:Akashi-TanakaSadakoS
,
pubmed-author:AndoMasashiM
,
pubmed-author:FujiwaraYasuhiroY
,
pubmed-author:HojoTakashiT
,
pubmed-author:KatsumataNoriyukiN
,
pubmed-author:KinoshitaTakayukiT
,
pubmed-author:KohnoTsutomuT
,
pubmed-author:ShienTadahikoT
,
pubmed-author:ShimizuChikakoC
,
pubmed-author:YonemoriKanK
pubmed:issnType
Electronic
pubmed:volume
38
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
172-5
pubmed:meshHeading
pubmed-meshheading:18296424-Administration, Oral
,
pubmed-meshheading:18296424-Adult
,
pubmed-meshheading:18296424-Aged
,
pubmed-meshheading:18296424-Antimetabolites, Antineoplastic
,
pubmed-meshheading:18296424-Bone Neoplasms
,
pubmed-meshheading:18296424-Breast Neoplasms
,
pubmed-meshheading:18296424-Diarrhea
,
pubmed-meshheading:18296424-Disease Progression
,
pubmed-meshheading:18296424-Disease-Free Survival
,
pubmed-meshheading:18296424-Drug Administration Schedule
,
pubmed-meshheading:18296424-Drug Combinations
,
pubmed-meshheading:18296424-Female
,
pubmed-meshheading:18296424-Humans
,
pubmed-meshheading:18296424-Middle Aged
,
pubmed-meshheading:18296424-Nausea
,
pubmed-meshheading:18296424-Oxonic Acid
,
pubmed-meshheading:18296424-Retrospective Studies
,
pubmed-meshheading:18296424-Tegafur
pubmed:year
2008
pubmed:articleTitle
Clinical efficacy of S-1 in pretreated metastatic breast cancer patients.
pubmed:affiliation
Division of Surgical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
pubmed:publicationType
Journal Article